» Articles » PMID: 9430587

Cancer Treatment by Targeted Drug Delivery to Tumor Vasculature in a Mouse Model

Overview
Journal Science
Specialty Science
Date 1998 Feb 7
PMID 9430587
Citations 462
Authors
Affiliations
Soon will be listed here.
Abstract

In vivo selection of phage display libraries was used to isolate peptides that home specifically to tumor blood vessels. When coupled to the anticancer drug doxorubicin, two of these peptides-one containing an alphav integrin-binding Arg-Gly-Asp motif and the other an Asn-Gly-Arg motif-enhanced the efficacy of the drug against human breast cancer xenografts in nude mice and also reduced its toxicity. These results indicate that it may be possible to develop targeted chemotherapy strategies that are based on selective expression of receptors in tumor vasculature.

Citing Articles

SynBioNanoDesign: pioneering targeted drug delivery with engineered nanomaterials.

Cai Q, Guo R, Chen D, Deng Z, Gao J J Nanobiotechnology. 2025; 23(1):178.

PMID: 40050980 PMC: 11884119. DOI: 10.1186/s12951-025-03254-9.


CD13 as a potential theranostic target for prostate-specific membrane antigen-negative prostate cancer and first-in-human study of [F]AlF-CD13-L1 PET/CT imaging.

Tang W, Zhou M, Lu C, Qi L, Zhang Y, Tang Y Eur J Nucl Med Mol Imaging. 2025; .

PMID: 39985618 DOI: 10.1007/s00259-025-07140-2.


Sulforaphane Wrapped in Self-Assembled Nanomicelle Enhances the Effect of Sonodynamic Therapy on Glioma.

Li Y, Yang X, Wei Z, Niu H, Wu L, Chen C Pharmaceutics. 2025; 17(1).

PMID: 39861683 PMC: 11769538. DOI: 10.3390/pharmaceutics17010034.


Enhancing Tumor Targeted Therapy: The Role of iRGD Peptide in Advanced Drug Delivery Systems.

Nikitovic D, Kukovyakina E, Berdiaki A, Tzanakakis A, Luss A, Vlaskina E Cancers (Basel). 2024; 16(22).

PMID: 39594723 PMC: 11592346. DOI: 10.3390/cancers16223768.


Polypeptides-Based Nanocarriers in Tumor Therapy.

You J, Guo Y, Dong Z Pharmaceutics. 2024; 16(9).

PMID: 39339228 PMC: 11435007. DOI: 10.3390/pharmaceutics16091192.